Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1Breast 1

Conditions

Severe Combined Immunodeficiency 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Mucopolysaccharidosis I 1Hematologic Neoplasms 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 447Surgical Procedures, Operative 165Observation 152Drug Therapy 143Radiotherapy 142Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 79Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 67Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 62Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Prospective Studies × Clear all
NCT00695279 2024-10-30

Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products

St. Jude Children's Research Hospital

Completed
41 enrolled
CNSOther hematologic neoplasm

Mucopolysaccharidosis I, Neoplasms, Neuroblastoma, Severe Combined Immunodeficiency, Hematologic Neoplasms

NCT02536625 2021-02-04

RAPANK

Centre Leon Berard

Completed
62 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡